Sort
15,273 grants matching “antimicrobial resistance”
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance
$810,000Anthony Bernard Schryvers · University Of Calgary · R01 · FY2021 · AI
Targeting Estrogenic pathways in Tregs to promote ARDS resolution
$809,772Franco Rafael D'alessio · Johns Hopkins University · R01 · FY2023 · HL
Targeted Clinical Research Program to Address Selected Viral Infections
$809,771Richard Whitley · University Of Alabama At Birmingham · N01 · FY2015 · AI
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.
$809,476Joseph A Duncan · Univ Of North Carolina Chapel Hill · U01 · FY2021 · AI
Impact of polymicrobial interactions and within-host adaptation on CAUTI pathogenesis
$809,427Chelsie Elizabeth Armbruster · State University Of New York At Buffalo · R01 · FY2025 · DK
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
$808,735John R Kirby · University Of Iowa · R01 · FY2016 · AI
Task 4: The Interventional Agent Development Services Program
$808,268Jon Carl Mirsalis · Sri International · N01 · FY2016 · AI
Task D06: Nonclinical Microbiological, Safety, Toxicology, and Pharmacokinetic Services
$806,758Jon Mirsalis · Sri International · N01 · FY2020 · AI
Signal-Based Analysis of Clinical Microbiology
$806,636Vecna Technologies, Inc. · R44 · FY2004 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$806,468John R. Chan · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$806,468John R. Chan · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
$805,715John R Kirby · University Of Iowa · R01 · FY2015 · AI
Optimizing Inhibitors of T. gondii ENR
$805,607Rima L McLeod · University Of Chicago · U01 · FY2013 · AI
PrEP and dPEP: Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis
$805,259Jared Baeten · University Of Washington · R01 · FY2021 · AI
Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa
$805,095Brian Tsuji · State University Of New York At Buffalo · R01 · FY2022 · AI
Markers of Nephrotoxicity during treatment with Antibiotic Combinations: The MONACO clinical trial
$804,993Todd Anthony Miano · University Of Pennsylvania · R01 · FY2025 · DK
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$804,593Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2024 · AI
NGS based metagenomic screening of ocular infections
$803,560Espoir Kyubwa · Chromologic, Llc · R42 · FY2024 · EY
An Expanded Multivalent Vaccine to Prevent MDR Shigella and ETEC Disease
$803,296Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2021 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid
$803,134Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2013 · AI
Novel Biamyxins targeting multidrug resistant Gram-negative bacterial infections
$802,798Yanan Zhao · State University Of New York At Buffalo · R01 · FY2024 · AI
Personalized Antimicrobial Combinations to Combat Resistance
$802,525Vincent H Tam · University Of Houston · R01 · FY2024 · AI
RNA: New Antimicrobial Strategies
$802,250Adrian Ferre-D'amare · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Immunotherapy to prevent drug-resistant tuberculosis
$802,216Rhea N Coler · Access To Advanced Health Institute · R01 · FY2019 · AI
Safe Pregnancy by Infectious Disease Control in Kinshasa
$802,082Carl Bose · Univ Of North Carolina Chapel Hill · U01 · FY2007 · HD